hepatitis C

Inside the $100 million ad blitz for a $1,100-a-pill drug for hepatitis C
Stat
Wed, 03/9/16 - 10:31 am
hepatitis C
drug ads
Harvoni
Gilead Sciences
Gilead, Merck Spar Over Hepatitis C $1,000-Pill Royalties
Bloomberg
Mon, 03/7/16 - 09:58 pm
Gilead Sciences
Merck
hepatitis C
Sovaldi
Harvoni
Gilead's 3 Most Profitable Lines of Business
Investopedia
Mon, 03/7/16 - 09:44 am
Gilead Sciences
Truvada
Sovaldi
Harvoni
hepatitis C
hepatitis B
HIV
Gilead: Hep C Prescriptions Hold at 94% Among New Patients
Barron's
Fri, 03/4/16 - 02:48 pm
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
Will Merck Encroach On Gilead's Harvoni Territory?
Yahoo/Benzinga
Tue, 02/23/16 - 05:44 pm
Merck
Gilead
Harvoni
AbbVie
hepatitis C
Viekira Pak
Zepatier
Should Gilead Investors Fear Regulus?
Seeking Alpha
Thu, 02/18/16 - 09:37 am
Gilead Sciences
Regulus
hepatitis C
Harvoni
RG-101
Regulus Bolsters Argument for Effective Hepatitis C Injection
TheStreet.com
Wed, 02/17/16 - 11:36 am
Regulus
hepatitis C
RG-101
Harvoni’s New Label Gives Gilead Edge Over AbbVie
Bidness, ETC
Wed, 02/17/16 - 10:42 am
Harvoni
labeling
Gilead Sciences
AbbVie
Viekira Pak
hepatitis C
Merck's new hep C contender Zepatier faces a long runway, but 2017 could bring takeoff
Fierce Pharma Marketing
Wed, 02/17/16 - 10:33 am
Merck
hepatitis C
Zepatier
Express Scripts
Curing Hepatitis C: How Gilead Sciences Plans to Beat Merck
Motley Fool
Tue, 02/9/16 - 09:21 am
hepatitis C
Merck
Gilead Sciences
Zepatier
Harvoni
1 Company Gilead Sciences Should Consider Buying Right Now
Motley Fool
Sat, 02/6/16 - 12:28 pm
Gilead Sciences
M&A
hepatitis C
Intercept Pharma
Gilead Sciences: Why Slowing Hep-C Sales Don’t Matter
Barron's
Fri, 02/5/16 - 09:40 pm
Gilead Sciences
hepatitis C
Here's Why Johnson & Johnson's Sales Fell Last Year
Motley Fool
Sun, 01/31/16 - 01:34 pm
JNJ
earnings
hepatitis C
Merck Takes on Gilead With Sharply Lower Hepatitis C Drug Price
TheStreet.com
Fri, 01/29/16 - 10:34 am
Merck
Gilead Sciences
hepatitis C
Zepatier
drug pricing
Yes, Gilead put superhigh prices on hep C drugs, but what can you do? Senators ask
Fierce Pharma
Sat, 01/23/16 - 11:07 am
Gilead Sciences
drug pricing
hepatitis C
AbbVie Is Expected to Strengthen Its Position in Virology in 4Q15
Yahoo/Market Realist
Tue, 01/19/16 - 09:28 am
AbbVie
hepatitis C
Lupron
Duodopa
Creon
Viekira Pak
3 Slides Suggesting Gilead Sciences May Be Unstoppable
Motley Fool
Tue, 01/12/16 - 02:41 pm
Gilead Sciences
HIV
hepatitis C
oncology
Why Gilead Is 'The Apple Of Biotech'
Yahoo/Benzinga
Fri, 01/8/16 - 09:32 am
Gilead Sciences
hepatitis C
Apple
Gilead grabs priority review for pangenotype hep C combo; Hep B med shown to be safe
BioPharma Dive
Wed, 01/6/16 - 11:01 am
Gilead Sciences
hepatitis C
hepatitis B
Sovaldi + velpatasvir
Viread
3 Potential Blockbuster Drugs Launching in 2016
Investors.com
Wed, 01/6/16 - 10:57 am
Merck
hepatitis C
elbasvir/grazoprevir
Gilead Sciences
sofosbuvir/velpatasvir
Eli Lilly
psoriasis
ixekizumab

Pages